These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26404045)

  • 1. [V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].
    Pardo F; Pons JA; Briceño J;
    Gastroenterol Hepatol; 2015 Dec; 38(10):600-18. PubMed ID: 26404045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list.
    Pardo F; Pons JA; Briceño J;
    Cir Esp; 2015 Dec; 93(10):619-37. PubMed ID: 26187597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VI consensus document by the Spanish Liver Transplantation Society.
    Pardo F; Pons JA; Castells L; Colmenero J; Gómez MÁ; Lladó L; Pérez B; Prieto M; Briceño J
    Gastroenterol Hepatol; 2018; 41(6):406-421. PubMed ID: 29866511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VI consensus document by the Spanish Liver Transplantation Society.
    Pardo F; Pons JA; Castells L; Colmenero J; Gómez MÁ; Lladó L; Pérez B; Prieto M; Briceño J
    Cir Esp (Engl Ed); 2018; 96(6):326-341. PubMed ID: 29776591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific issues concerning the management of patients on the waiting list and after liver transplantation.
    Burra P; Giannini EG; Caraceni P; Ginanni Corradini S; Rendina M; Volpes R; Toniutto P
    Liver Int; 2018 Aug; 38(8):1338-1362. PubMed ID: 29637743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
    Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
    Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
    Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
    Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Terrault NA; McCaughan GW; Curry MP; Gane E; Fagiuoli S; Fung JYY; Agarwal K; Lilly L; Strasser SI; Brown KA; Gadano A; Kwo PY; Burra P; Samuel D; Charlton M; Pessoa MG; Berenguer M
    Transplantation; 2017 May; 101(5):945-955. PubMed ID: 28437387
    [No Abstract]   [Full Text] [Related]  

  • 9. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IV Consensus meeting of the Spanish Society of Liver Transplantation (SETH) 2012. Liver transplant with non-conventional grafts: Split liver transplantation and non-heart beating donors].
    Abradelo M; Fondevila C;
    Cir Esp; 2014 Mar; 92(3):157-67. PubMed ID: 24369829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.
    Berenguer M; Charco R; Manuel Pascasio J; Ignacio Herrero J
    Liver Int; 2012 May; 32(5):712-31. PubMed ID: 22221843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus document from the Spanish Society for Liver Transplantation: Enhanced recovery after liver transplantation.
    Lladó L; Abradelo de Usera M; Blasi A; Gutiérrez R; Montalvá E; Pascual S; Rodríguez-Laiz G;
    Gastroenterol Hepatol; 2024 Feb; 47(2):206-217. PubMed ID: 38342510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus document from the Spanish Society for Liver Transplantation: enhanced recovery after liver transplantation.
    Lladó L; Usera MA; Blasi A; Gutiérrez R; Montalvá E; Pascual S; Rodríguez-Laiz G;
    Cir Esp (Engl Ed); 2024 Feb; 102(2):104-115. PubMed ID: 38403385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the management of the liver transplant patient.
    Kwong AJ; Fix OK
    Curr Opin Gastroenterol; 2015 May; 31(3):224-32. PubMed ID: 25774445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Majno P; Berney T; Morel P; Mentha G; Combescure C
    Transpl Int; 2014 Jul; 27(7):686-95. PubMed ID: 24649861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
    Mehta N; Sarkar M; Dodge JL; Fidelman N; Roberts JP; Yao FY
    Liver Transpl; 2016 Feb; 22(2):178-87. PubMed ID: 26479422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Orthotopic liver transplantation (first clinical experience)].
    Konstantinov BA; Eramishantsev AK; Goté SV; Tsirulńikova OM; Skipenko OG; Lebezev VM; Shertsinger AG; Lokshin LS
    Khirurgiia (Mosk); 1993 Mar; (3):32-44. PubMed ID: 8089967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.